IL246148A0 - Treating brain disorders and biomarkers related thereto - Google Patents
Treating brain disorders and biomarkers related theretoInfo
- Publication number
- IL246148A0 IL246148A0 IL246148A IL24614816A IL246148A0 IL 246148 A0 IL246148 A0 IL 246148A0 IL 246148 A IL246148 A IL 246148A IL 24614816 A IL24614816 A IL 24614816A IL 246148 A0 IL246148 A0 IL 246148A0
- Authority
- IL
- Israel
- Prior art keywords
- treatment
- related symptoms
- brain disorders
- disorders
- brain
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Radiology & Medical Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- High Energy & Nuclear Physics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cardiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361915835P | 2013-12-13 | 2013-12-13 | |
| PCT/US2014/070340 WO2015089503A2 (en) | 2013-12-13 | 2014-12-15 | Methods of treating brain disorders or identifying biomarkers related thereto |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL246148A0 true IL246148A0 (en) | 2016-07-31 |
Family
ID=53371976
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL246148A IL246148A0 (en) | 2013-12-13 | 2016-06-09 | Treating brain disorders and biomarkers related thereto |
| IL276431A IL276431A (en) | 2013-12-13 | 2020-08-02 | Treatment of the brain disorders and related symptoms |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL276431A IL276431A (en) | 2013-12-13 | 2020-08-02 | Treatment of the brain disorders and related symptoms |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20160345855A1 (https=) |
| EP (2) | EP3079579A4 (https=) |
| JP (2) | JP2017500306A (https=) |
| CN (2) | CN106102762A (https=) |
| AU (2) | AU2014361822A1 (https=) |
| CA (1) | CA2933372A1 (https=) |
| IL (2) | IL246148A0 (https=) |
| MX (1) | MX2016007716A (https=) |
| WO (1) | WO2015089503A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2018530593A (ja) * | 2015-10-16 | 2018-10-18 | ノースウェスタン ユニバーシティ | 統合失調症、双極性障害、認知障害及び大うつ病性障害の治療のための非定型的抗精神病薬ならびにｎｍｄａ調節剤の医薬品の組み合わせ |
| US20220024976A1 (en) * | 2019-01-11 | 2022-01-27 | Naurex Inc. | Salt and crystalline forms of rapastinel |
| CN110123342B (zh) * | 2019-04-17 | 2021-06-08 | 西北大学 | 一种基于脑电波的网瘾检测方法及系统 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040122090A1 (en) * | 2001-12-07 | 2004-06-24 | Lipton Stuart A. | Methods for treating neuropsychiatric disorders with nmda receptor antagonists |
| US20050273017A1 (en) * | 2004-03-26 | 2005-12-08 | Evian Gordon | Collective brain measurement system and method |
| US20090253982A1 (en) * | 2006-04-03 | 2009-10-08 | Jiongjiong Wang | Assessing subject's reactivity to psychological stress using fmri |
| CN101505745A (zh) * | 2006-06-15 | 2009-08-12 | 玛尔斯有限公司 | 改善认知功能的方法和组合物 |
| US8951968B2 (en) * | 2009-10-05 | 2015-02-10 | Northwestern University | Methods of treating depression and other related diseases |
| PL2485751T3 (pl) * | 2009-10-05 | 2014-10-31 | Univ Northwestern | GLYX-13 do stosowania w sposobie leczenia depresji opornej na leczenie |
| US20140107037A1 (en) * | 2011-04-27 | 2014-04-17 | Northwestern University | Methods of treating alzheimer's disease, huntington's disease, autism, or other disorders |
| WO2013106084A1 (en) * | 2012-01-09 | 2013-07-18 | Takeda Pharmaceutical Company Limited | Methods and drug products for treating alzheimer's disease |
-
2014
- 2014-12-15 MX MX2016007716A patent/MX2016007716A/es unknown
- 2014-12-15 WO PCT/US2014/070340 patent/WO2015089503A2/en not_active Ceased
- 2014-12-15 US US15/104,223 patent/US20160345855A1/en not_active Abandoned
- 2014-12-15 EP EP14870211.1A patent/EP3079579A4/en not_active Withdrawn
- 2014-12-15 JP JP2016538538A patent/JP2017500306A/ja active Pending
- 2014-12-15 AU AU2014361822A patent/AU2014361822A1/en not_active Abandoned
- 2014-12-15 CA CA2933372A patent/CA2933372A1/en not_active Abandoned
- 2014-12-15 CN CN201480068036.1A patent/CN106102762A/zh active Pending
- 2014-12-15 EP EP20174673.2A patent/EP3721799A1/en not_active Withdrawn
- 2014-12-15 CN CN202010314939.0A patent/CN111920412A/zh active Pending
-
2016
- 2016-06-09 IL IL246148A patent/IL246148A0/en unknown
-
2019
- 2019-08-26 JP JP2019153406A patent/JP2020007333A/ja active Pending
- 2019-11-13 AU AU2019264583A patent/AU2019264583A1/en not_active Abandoned
-
2020
- 2020-08-02 IL IL276431A patent/IL276431A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3721799A1 (en) | 2020-10-14 |
| WO2015089503A3 (en) | 2015-10-01 |
| JP2020007333A (ja) | 2020-01-16 |
| AU2014361822A1 (en) | 2016-07-28 |
| EP3079579A2 (en) | 2016-10-19 |
| CN106102762A (zh) | 2016-11-09 |
| AU2019264583A1 (en) | 2019-12-05 |
| CA2933372A1 (en) | 2015-06-18 |
| US20160345855A1 (en) | 2016-12-01 |
| MX2016007716A (es) | 2017-03-31 |
| WO2015089503A2 (en) | 2015-06-18 |
| IL276431A (en) | 2020-09-30 |
| CN111920412A (zh) | 2020-11-13 |
| JP2017500306A (ja) | 2017-01-05 |
| EP3079579A4 (en) | 2017-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL283943A (en) | Use of pyrazolopyrimidine derivatives for the treatment of pi3k related disorders | |
| IL273688A (en) | Evaluation and treatment of bradykinin-mediated disorders | |
| HUE061618T2 (hu) | Vegyület szemrendellenességek kezelésére | |
| EP2983657A4 (en) | TREATMENT OF GASTROINTESTINAL AND OTHER DISEASES | |
| PT2919796T (pt) | Utilização de akkermansia para o tratamento de distúrbios metabólicos | |
| HUE056006T2 (hu) | Kombináció Parkinson-kór kezelésére | |
| PL3060252T3 (pl) | Zastosowanie cząsteczek wiążących semaforynę-4D do leczenia zaburzeń neurodegeneracyjnych | |
| IL239957A0 (en) | Assessment, testing and treatment of pkal mediated disorders | |
| HUE043206T2 (hu) | Kortisztatin-analógok gyulladásos és/vagy immunbetegségek kezelésére | |
| HUE042763T2 (hu) | Módosított szerpinek vérzési rendellenességek kezelésére | |
| HUE037663T2 (hu) | Kalcitonin mimetikumok betegségek és rendellenességek kezelésére | |
| HUE037179T2 (hu) | Gyógyászati kompozíciók izom-rendellenességek kezelésére | |
| PL2961426T3 (pl) | Leczenie zaburzeń ośrodkowego układu nerwowego przez donosowe podawanie immunoglobuliny g | |
| EP2996771A4 (en) | TREATMENT OF HUMILION AND FEAR STROKES | |
| ZA201507724B (en) | The treatment of inflammatory disorders | |
| HUE045148T2 (hu) | Bumetanid parkinson-szindrómás neurodegeneratív betegségek kezelésére | |
| HUE048500T2 (hu) | Elõnedvesített törlõkendõk anális-rektális irritációk és rendellenességek kezelésére | |
| SI2986325T1 (sl) | Postopki zdravljenja motenj ciklusa sečnine | |
| IL276431A (en) | Treatment of the brain disorders and related symptoms | |
| IL242516B (en) | Treatment of pulmonary and other conditions | |
| HUE047174T2 (hu) | Imepitoin epilepsziás rendellenességek kezelésére történõ alkalmazásra macskafélékben | |
| TH1401003827A (th) | องค์ประกอบและวิธีการต่างๆ สำหรับการรักษาโรคและความผิดปกติเกี่ยวกับตับ | |
| GB201306413D0 (en) | The local treatment of ophthalmic diseases |